Published in Ann Oncol on February 06, 2014
Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma. Ann Surg Oncol (2014) 1.02
Patterns of metastasis in colon and rectal cancer. Sci Rep (2016) 0.93
Strategies to Prevent "Bad Luck" in Cancer. J Natl Cancer Inst (2015) 0.92
The landscape of metastatic progression patterns across major human cancers. Oncotarget (2015) 0.91
Pattern of distant metastases in colorectal cancer: a SEER based study. Oncotarget (2015) 0.90
Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands. Int J Colorectal Dis (2014) 0.89
Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer. Medicine (Baltimore) (2015) 0.86
Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol (2015) 0.86
The Increasing Relevance of Tumour Histology in Determining Oncological Outcomes in Colorectal Cancer. Curr Colorectal Cancer Rep (2015) 0.83
Limited effect of lymph node status on the metastatic pattern in colorectal cancer. Oncotarget (2016) 0.82
Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum. World J Gastroenterol (2016) 0.79
Reduced rate of copy number aberrations in mucinous colorectal carcinoma. Oncotarget (2015) 0.79
The molecular background of mucinous carcinoma beyond MUC2. J Pathol Clin Res (2014) 0.76
Younger Age Is Associated with Poorer Survival in Patients with Signet-Ring Cell Carcinoma of the Colon without Distant Metastasis. Gastroenterol Res Pract (2016) 0.75
An unusual pain in the hip. Oxf Med Case Reports (2016) 0.75
Early-Onset Signet-Ring Cell Adenocarcinoma of the Colon: A Case Report and Review of the Literature. Case Rep Oncol Med (2017) 0.75
Systematic review: brain metastases from colorectal cancer-Incidence and patient characteristics. BMC Cancer (2016) 0.75
Mucinous Subtype in Patients With Colorectal Cancer. Ann Coloproctol (2017) 0.75
Signet ring colorectal carcinoma: Do we need to improve the treatment algorithm? World J Gastrointest Oncol (2016) 0.75
Prognosis and value of preoperative radiotherapy in locally advanced rectal signet-ring cell carcinoma. Sci Rep (2017) 0.75
Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experience. J Gastrointest Oncol (2017) 0.75
Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients. Oncotarget (2016) 0.75
Prognostic factors of surgically-treated patients with cancer of the right colon: a ten years' experience of a single universitary institution. Arq Bras Cir Dig (2015) 0.75
Macroscopic serosal classification of colorectal cancer and its clinical significance. Int J Clin Exp Med (2015) 0.75
Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations. Clin Med Insights Oncol (2017) 0.75
Development of Halofluorochromic Polymer Nanoassemblies for the Potential Detection of Liver Metastatic Colorectal Cancer Tumors Using Experimental and Computational Approaches. Pharm Res (2017) 0.75
Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer. Sci Rep (2017) 0.75
Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies. PLoS One (2017) 0.75
Prognostic relevance of histopathological features in signet ring cell carcinoma of the colorectum. Virchows Arch (2016) 0.75
Patterns of metastatic progression after definitive radiation therapy for early-stage and locally advanced non-small cell lung cancer. Clin Exp Metastasis (2017) 0.75
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med (2001) 13.75
Metastatic patterns in adenocarcinoma. Cancer (2006) 4.16
Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol (2007) 3.53
Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med (2008) 3.19
Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol (1986) 2.93
Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol (2005) 2.51
Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer (2010) 2.13
Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery (2006) 1.96
Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol (2012) 1.82
Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur J Cancer (2012) 1.73
Mucinous neoplasms of the appendix and peritoneum. Arch Pathol Lab Med (2011) 1.62
Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut (2010) 1.50
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. Br J Cancer (2009) 1.48
Critical analysis of mucin and signet ring cell as prognostic factors in an Asian population of 2,764 sporadic colorectal cancers. Int J Colorectal Dis (2010) 1.24
Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer. Ann Surg Oncol (2011) 1.16
Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. Ann Oncol (2011) 1.11
Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma. Ann Oncol (2013) 0.95
Clinical significance of signet ring cell rectal carcinoma. Int J Colorectal Dis (2003) 0.93
Mucinous colorectal carcinoma. J Surg Oncol (2001) 0.90
Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer. Clin Colorectal Cancer (2012) 0.89
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med (2001) 13.75
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol (2004) 6.47
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol (2012) 5.32
Risk factors for anastomotic failure after total mesorectal excision of rectal cancer. Br J Surg (2005) 3.57
Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. J Clin Oncol (2005) 2.77
Gastric cancer: epidemiology, pathology and treatment. Ann Oncol (2003) 2.53
Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys (2003) 2.38
Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol (2006) 2.30
No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol (2001) 2.20
KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients. Br J Cancer (2011) 2.16
Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg (2002) 2.13
Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery. Br J Surg (2009) 2.00
Value of palliative resection in gastric cancer. Br J Surg (2002) 1.90
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol (2009) 1.87
Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol (2002) 1.78
Urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg (2008) 1.75
Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev (2007) 1.68
Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma. Br J Surg (2007) 1.57
Neoadjuvant chemotherapy for operable breast cancer. Br J Surg (2007) 1.55
Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer (2012) 1.54
Implementation of a short-stay programme after breast cancer surgery. Br J Surg (2010) 1.54
Sentinel lymph node biopsy in breast cancer. Ann Oncol (2002) 1.54
Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer. Br J Surg (2009) 1.48
Variations in treatment policies and outcome for bladder cancer in the Netherlands. Eur J Surg Oncol (2010) 1.47
Origin of presacral local recurrence after rectal cancer treatment. Br J Surg (2010) 1.47
[Clear-cut beneficial effect of breast cancer screening on the trend in breast-conserving surgery]. Ned Tijdschr Geneeskd (2002) 1.43
[The abdominal compartment syndrome]. Ned Tijdschr Geneeskd (2005) 1.41
Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. Br J Surg (2011) 1.40
Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg 2006; 93; 872-878). Br J Surg (2007) 1.40
Imaging for predicting the risk factors--the circumferential resection margin and nodal disease--of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR (2005) 1.39
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol (2004) 1.39
[The treatment of patients with gastric carcinoma based on the results of Dutch studies]. Ned Tijdschr Geneeskd (2005) 1.39
Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854). Breast Cancer Res Treat (2013) 1.39
Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer. Br J Cancer (2005) 1.38
Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis. Breast Cancer Res Treat (2013) 1.31
Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis (2012) 1.30
Patient's needs and preferences in routine follow-up after treatment for breast cancer. Br J Cancer (2004) 1.30
Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat (2010) 1.27
Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol (2004) 1.27
Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol (2007) 1.25
Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. Br J Cancer (2010) 1.21
Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol (2010) 1.19
A systematic review and meta-analysis of the volume-outcome relationship in the surgical treatment of breast cancer. Are breast cancer patients better of with a high volume provider? Eur J Surg Oncol (2010) 1.19
Volume and outcome in colorectal cancer surgery. Eur J Surg Oncol (2010) 1.17
Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer (2006) 1.16
Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol (2006) 1.15
Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients. Br J Cancer (2004) 1.14
Gastric cancers in young and elderly patients show different genomic profiles. J Pathol (2007) 1.14
Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg (2013) 1.14
Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol (2006) 1.13
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer (2005) 1.10
Long-term survival and occasional regression of distant melanoma metastases after adrenal metastasectomy. Ann Surg Oncol (2008) 1.09
Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer (2009) 1.08
The Dutch surgical colorectal audit. Eur J Surg Oncol (2013) 1.08
Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells. Cancer Immunol Immunother (2004) 1.08
Natural killer cells infiltrating colorectal cancer and MHC class I expression. Mol Immunol (2005) 1.08
Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences. Br J Cancer (2007) 1.08
Differences in outcomes of oesophageal and gastric cancer surgery across Europe. Br J Surg (2012) 1.08
Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis. Br J Surg (2012) 1.06
Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era? Aliment Pharmacol Ther (1999) 1.06
Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. Eur J Surg Oncol (2009) 1.05
Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer (2002) 1.05
Treatment of liver metastases of colorectal cancer. Ann Oncol (2005) 1.04
The prognostic role of TGF-β signaling pathway in breast cancer patients. Ann Oncol (2012) 1.04
Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989-2006. Eur J Cancer (2010) 1.04
Near-infrared fluorescence imaging in patients undergoing pancreaticoduodenectomy. Eur Surg Res (2011) 1.03
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer. Br J Cancer (2006) 1.03
Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification. Eur J Surg Oncol (2010) 1.03
Total pelvic exenteration for primary and recurrent malignancies. World J Surg (2009) 1.02
Risk factors for faecal incontinence after rectal cancer treatment. Br J Surg (2007) 1.02
Results of a national survey among Dutch surgeons treating patients with colorectal carcinoma. Current opinion about follow-up, treatment of metastasis, and reasons to revise follow-up practice. Colorectal Dis (2007) 1.02
Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer. Br J Cancer (2013) 1.01
Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer. Ann Oncol (2013) 1.01
Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial. World J Surg (2005) 1.01
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br J Cancer (2008) 1.00
Improving quality of cancer care through surgical audit. Eur J Surg Oncol (2010) 1.00
Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge. Eur J Cancer (2013) 0.99
Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis. Eur J Cancer (2003) 0.99
The preferred treatment for young women with breast cancer--mastectomy versus breast conservation. Breast (2006) 0.98
Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis. Ann Oncol (2013) 0.98
Intraoperative near-infrared fluorescence imaging of colorectal metastases targeting integrin α(v)β(3) expression in a syngeneic rat model. Eur J Surg Oncol (2011) 0.97
Improved diagnosis and treatment of anastomotic leakage after colorectal surgery. Eur J Surg Oncol (2008) 0.97
Nerve sparing radical hysterectomy: latest developments and historical perspective. Crit Rev Oncol Hematol (2003) 0.97
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries. Br J Surg (2010) 0.96
Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer (2002) 0.96
Isolated limb perfusion for melanoma patients--a review of its indications and the role of tumour necrosis factor-alpha. Eur J Surg Oncol (2006) 0.96
Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol (2010) 0.96
Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases. Ann Oncol (2009) 0.95
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study. Breast Cancer Res Treat (2012) 0.95
Combining process indicators to evaluate quality of care for surgical patients with colorectal cancer: are scores consistent with short-term outcome? BMJ Qual Saf (2012) 0.95
Cervical lymph node dissection for metastatic testicular cancer. Ann Surg Oncol (2010) 0.95
Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer. Br J Cancer (2011) 0.95
Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma. Ann Oncol (2013) 0.95
Prevention of seroma formation after axillary dissection in breast cancer: a systematic review. Eur J Surg Oncol (2011) 0.95
Expression of cell adhesion molecules and prognosis in breast cancer. Br J Surg (2012) 0.95
'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome. Colorectal Dis (2010) 0.95
High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer (2006) 0.94